Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis
- PMID: 25400433
- PMCID: PMC4229514
- DOI: 10.3748/wjg.v20.i42.15476
Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis
Abstract
Hepatitis C is a liver disease that is transmitted through contact with the blood of an infected person. An estimated 150 million individuals worldwide have been chronically infected with the hepatitis C virus (HCV). Hepatitis C shows significant genetic variation in the global population, due to the high rate of viral RNA mutation. There are six variants of the virus (HCV genotypes 1, 2, 3, 4, 5, and 6), with 15 recorded subtypes that vary in prevalence across different regions of the world. A variety of devices are used to diagnose hepatitis C, including HCV antibody test, HCV viral load test, HCV genotype test and liver biopsy. Rapid, inexpensive, sensitive, and robust analytical devices are therefore essential for effective diagnosis and monitoring of disease treatment. This review provides an overview of current electrochemical immunosensor and genosensor technologies employed in HCV detection. There are a limited number of publications showing electrochemical biosensors being used for the detection of HCV. Due to their simplicity, specificity, and reliability, electrochemical biosensor devices have potential clinical applications in several viral infections.
Keywords: Diagnostic tests; Electrochemical detection; Genosensors; Hepatitis C virus; Immunosensors.
Figures
References
-
- Tang D, Tang J, Su B, Li Q, Chen G. Electrochemical detection of hepatitis C virus with signal amplification using BamHI endonuclease and horseradish peroxidase-encapsulated nanogold hollow spheres. Chem Commun (Camb) 2011;47:9477–9479. - PubMed
-
- Center for Disease Control and Prevention. Hepatitis C Information for Health Professionals. Accessed in August 25, 2013. Available from: http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm.
-
- Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55 Suppl 1:S10–S15. - PubMed
-
- Torresi J, Johnson D, Wedemeyer H. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J Hepatol. 2011;54:1273–1285. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
